Semaglutide (Wegovy) stakeholder meeting outcome statement

PBAC

24 November 2021 - The outcome statement for the semaglutide stakeholder meeting held on 26 August 2021 is now available.

The PBAC convened a stakeholder meeting due to the high public health burden, and to help inform its future consideration of issues relating to the proposed PBS population and health outcomes to be valued.

Members of the PBAC, clinicians with expertise in the management of overweight and obesity, including a Staff Specialist in Endocrinology, Royal North Shore Hospital, representatives from the Obesity Collective, consumer groups, Novo Nordisk Pharmaceuticals, and the Department of Health were in attendance.

Read PBS News

Michael Wonder

Posted by:

Michael Wonder